Hjem › Diffust stort B-cellelymfom › Arizona › Scottsdale
Kliniske studier for Diffust stort B-cellelymfom i Scottsdale, AZ
5 studier for Diffust stort B-cellelymfom søker deltakere på steder i og rundt Scottsdale (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before CAR T-cell Therapy
RekruttererFase 2
- Mayo Clinic in Arizona, Scottsdale
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
RekruttererFase 1/2
- Honor Health Research Institute, Scottsdale
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
RekruttererFase 3
- Mayo Clinic - Arizona, Scottsdale
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
RekruttererFase 1
- Mayo Clinic - Scottsdale, Scottsdale
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
RekruttererFase 3
- Honor Health, Scottsdale
- Mayo Clinic Arizona, Scottsdale
Diffust stort B-cellelymfom-studier i andre byer
- New York City, NY21 studier
- Baldwin Park, CA19 studier
- Chicago, IL18 studier
- Los Angeles, CA17 studier
- Houston, TX17 studier
- Boston, MA16 studier
- Milwaukee, WI16 studier
- Portland, OR15 studier
- Nashville, TN15 studier
- Philadelphia, PA15 studier
- Durham, NC14 studier
- Dallas, TX13 studier
Andre studier i Scottsdale
- Kreft (alle typer)18 studier
- Brystkreft18 studier
- Metastatisk kreft17 studier
- Prostatakreft17 studier
- Ikke-småcellet lungekreft15 studier
- Kolorektal kreft15 studier
- Pankreaskreft13 studier
- Melanom10 studier
- Ulcerøs kolitt8 studier
- Lungekreft8 studier
- Alzheimers sykdom7 studier
- Leverkreft (hepatocellulært karcinom)7 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.